Hofseth BioCare ASA (OSL: HBC)
Norway
· Delayed Price · Currency is NOK 2.020
-0.030 (-1.46%)
Aug 30, 2024, 4:25 PM CET
Hofseth BioCare ASA Revenue
Hofseth BioCare ASA had revenue of 80.41M NOK in the quarter ending June 30, 2024, with 5.21% growth. This brings the company's revenue in the last twelve months to 230.08M, up 24.35% year-over-year. In the year 2023, Hofseth BioCare ASA had annual revenue of 218.51M with 81.42% growth.
Revenue (ttm)
230.08M
Revenue Growth
+24.35%
P/S Ratio
3.54
Revenue / Employee
3.29M
Employees
71
Market Cap
830.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 218.51M | 98.06M | 81.42% |
| Dec 31, 2022 | 120.45M | 32.83M | 37.47% |
| Dec 31, 2021 | 87.62M | 18.36M | 26.52% |
| Dec 31, 2020 | 69.25M | 1.47M | 2.17% |
| Dec 31, 2019 | 67.78M | 7.04M | 11.59% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 533.17M |
| Nordhealth AS | 471.77M |
| Nykode Therapeutics AS | 69.44M |
| Photocure ASA | 513.58M |
| Carasent ASA | 254.01M |
| ArcticZymes Technologies ASA | 117.80M |
| Gentian Diagnostics ASA | 151.51M |
| Navamedic ASA | 543.49M |
Hofseth BioCare ASA News
- 9 days ago - Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT - GlobeNewsWire
- 2 months ago - Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY - GlobeNewsWire
- 3 months ago - Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT - GlobeNewsWire
- 10 months ago - Hofseth Biocare ASA: THIRD QUARTER 2023 FINANCIAL REPORT - GlobeNewsWire
- 1 year ago - Hofseth Biocare ASA: FOURTH QUARTER 2022 & FULL YEAR FINANCIAL REPORT - GlobeNewsWire
- 2 years ago - Hofseth Biocare ASA: HOFSETH BIOCARE AWARDED BEST SUSTAINABLE BIOTECH COMPANY 2022 ACCOLADE - GlobeNewsWire
- 3 years ago - Hofseth Biocare ASA: GLOBAL INNOVATION PARTNERSHIP WITH CATALENT TO DEVELOP DELAYED-RELEASE FORMULATION OF OMEGO FISH OIL - GlobeNewsWire
- 3 years ago - Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION - GlobeNewsWire